Locations/Subsidiaries
Rodovia Castelo Branco, km. 32,5,
Itaqui - Trevo de Jandira,
Itapevi,
Brazil
1025 Boulevard Marcel Laurin,
St-Laurent,
Canada
Fax: 1 514 7449864
rue du Bosquet 15,
Louvain-la-Neuve,
Belgium
Fax: 32 10 494870
Avenida, Suba No. 95-66,
Bogota,
Colombia
Fax: 57 1 6018645
Five Giralda Farms,
Madison,
United States of America
Fax: 1 973 6605771
500 Arcola Road,
Collegeville,
United States of America
Avenida 1° de Mayo No. 127,
Col. San Andres Atoto,
Naucalpan,
Mexico
Fax: 52 55 21224444
Produktionsvej 12,
Glostrup,
Denmark
Fax: 45 44 888806
50 Minthorn Boulevard,
Markham,
Canada
Fax: 1 905 4704380
Storchengasse 1,
Vienna,
Austria
Fax: 43 1 89114 600
One Burtt Road,
Andover,
United States of America
Fort Dodge Animal Health
Huizerstraatweg 117,Naarden,
Netherlands
Fax: 31 35 6993380
Genetics Institute, LLC
87 Cambridgepark Drive,Cambridge,
United States of America
Wyeth Holdings Corporation
One Cyanamid Plaza,Wayne,
New Jersey,
United States of America
Fax: 201 831 2570
Wyeth Pharmaceuticals, Inc.
500 Arcola Road,Collegeville,
Pennsylvania,
United States of America
Fax: 1 610 995 4668
Intelligence
Studying Leukocyte Transendothelial Migration in Detail
Published by Phenom World
White Papers
Efficient Drug Registration Process Based on Document Management
Published by Infotehna Group
White Papers
Map Members
Published by ASEBIO
White Papers
Buy the latest industry research online today!
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues affecting the global nano-enabled drug delivery market. The report provides a comprehensive insight into the current and future application of nanotechnology in the drug delivery systems. It also provides an insight into the key drivers and barriers for the market growth. The report also provides a detailed analysis of the trends and its effects on the nano-enabled drug delivery market. The report also talks about the key regulations that affect the nanotechnology research and development and issues related to its use in pharmaceutical market. The report also details some case study of the latest technology being exploited in pharmaceutical industry. The report also provides detailed analysis of major deals that have happened in the nano-enabled drug delivery market landscape. At the end, the report looks into the future players. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts. The nano-enabled drug delivery market has been a high growth market and expected to grow at a faster rate in the near future. According to a study conducted by Willi Paul, and Chandra P. Sharma, the nano-enabled drug delivery market was $1.7 billion in 2009 and expected to reach over $4.8 billion in 2012. The market will witness increased competition, high investment from venture capitalist and government. The M&A and Licensing landscape will see significant changes in the coming future. This is because market is expected to become more lucrative in coming future. The major drivers for the market growth are Increasing acceptance of nano-enabled drugs, and a strong pipeline portfolio. The increasing governmental funding and R&D interest will strengthen the market in future. However, lack of consistent policy on technology transfer, poor R&D facility, and tight audit control and lack of centralized system will restrain the market growth. The nano-enabled drug delivery market has strong pipeline. The pipeline is primarily dominated by molecules in early stage of development. This suggests that the there is high level of R&D investment. This will support the future market and will fuel the licensing activity. Reports Buy online from $3500
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues affecting the global nano-enabled drug delivery market. The report provides a comprehensive insight into the current and future application of nanotechnology in the drug delivery systems. It also provides an insight into the key drivers and barriers for the market growth. The report also provides a detailed analysis of the trends and its effects on the nano-enabled drug delivery market. The report also talks about the key regulations that affect the nanotechnology research and development and issues related to its use in pharmaceutical market. The report also details some case study of the latest technology being exploited in pharmaceutical industry. The report also provides detailed analysis of major deals that have happened in the nano-enabled drug delivery market landscape. At the end, the report looks into the future players. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts. The nano-enabled drug delivery market has been a high growth market and expected to grow at a faster rate in the near future. According to a study conducted by Willi Paul, and Chandra P. Sharma, the nano-enabled drug delivery market was $1.7 billion in 2009 and expected to reach over $4.8 billion in 2012. The market will witness increased competition, high investment from venture capitalist and government. The M&A and Licensing landscape will see significant changes in the coming future. This is because market is expected to become more lucrative in coming future. The major drivers for the market growth are Increasing acceptance of nano-enabled drugs, and a strong pipeline portfolio. The increasing governmental funding and R&D interest will strengthen the market in future. However, lack of consistent policy on technology transfer, poor R&D facility, and tight audit control and lack of centralized system will restrain the market growth. The nano-enabled drug delivery market has strong pipeline. The pipeline is primarily dominated by molecules in early stage of development. This suggests that the there is high level of R&D investment. This will support the future market and will fuel the licensing activity. Reports Buy online from $3500
Suppliers Directory
Crossject - Needle-Free Device Technology
Crossject is a leader in the design and development of innovative needle-free device technology for the pharmaceutical industry.
Suppliers
Zuellig Pharma Specialty Solutions Group - Regional Clinical Trials Management (CTM) Solutions
Zuellig Pharma Specialty Solutions Group (SSG) is a pioneering regional consultancy and bio-logistic services division of Zuellig Pharma Asia Pacific. Strategically based in Singapore at the heart of Asia, SSG leverages Zuellig Pharma’s cutting-edge Regional Distribution Center (RDC) and pan-Asia coverage in 14 countries to provide customized, value-added bio-logistics for pharmaceutical, clinical trials, medical devices, diagnostics and other related companies.
Suppliers
IRIS Biotech - Peptide Synthesis and Pharmaceutical Intermediates
IRIS Biotech is specialised in reagents for peptide synthesis, PEGylation, life science research and biocatalysis.
Suppliers
NEUROFIT - Preclinical Research
NEUROFIT is a CRO (Contract Research Organisation) specialised in the evaluation of treatments for central (CNS) and peripheral nervous system (PNS) disorders, autoimmune diseases and for Oncology.
Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
